Brief: QSAM Biosciences Reports Reverse Stock Split Effective March 10, 2022
09/03/2022 22:33
March 9 (Reuters) - Qsam Biosciences Inc QSAM.PK :
* QSAM BIOSCIENCES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE
MARCH
10, 2022
* QSAM BIOSCIENCES INC - ANNOUNCED THAT A 1-FOR-40 REVERSE
STOCK
SPLIT OF COMPANY'S COMMON STOCK WILL BECOME EFFECTIVE ON
THURSDAY
Source text for Eikon: ID:nGNX3q4sSp
Further company coverage: QSAM.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qsam Biosciences
See all newsBrief: QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals
Brief: Qsam Biosciences Says Co Granted Telix An Additional 30 Days Under Exclusivity Period To Complete Its Due Diligence
Brief: Qsam Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals Receives $2 Million Pre-Closing Collaboration And Option Fee
Brief: Telix Pharmaceuticals Announces Proposed Acquisition Of QSAM Biosciences
Brief: Qsam Biosciences Provides Update To Shareholders On Phase 1 Progress And Preliminary Clinical Data